Back

Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in cancer patients: a systematic review and meta-analysis of heart failure hospitalisation and mortality.

25 April 2024 (09:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Managing cardiovascular risk in cancer patients Cardio-Oncology Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor James Meng

Norfolk And Norwich University Hospitals Nhs Foundation Trust, Norwich (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Cardiac rehabilitation and long-term prognosis in cardiovascular disease patients with cancer history
Mr T. Miki (Sagamihara, JP)
Abstract Slides
Presentation thumbnail
Physiological determinants underlying a meaningful improvement in VO2peak following exercise training in anthracycline-treated breast cancer survivors
Doctor S. Foulkes (Fitzroy, AU)
Abstract Slides
Presentation thumbnail
Cardiovascular health profile of cancer survivors: real-world insights from the Polish Norwegian Study (PONS)
Doctor G. Vaidean (Miami, US)
Abstract Slides
Presentation thumbnail
Peak oxygen uptake impairment in childhood cancer survivors treated with anthracycline-based chemotherapy: a systematic-review and meta-analysis
Doctor S. Foulkes (Fitzroy, AU)
Abstract Slides

Access the full session

Session thumbnail
Managing cardiovascular risk in cancer patients

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources